Regional differences in the effects of healthy aging on depressive symptoms: a Korean longitudinal study of aging (2006–2020)
Frontiers in Public Health · 16.01.2024 · 12
DOI: 10.3389/fpubh.2024.1256368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 16.01.2024. Verfasst von Soo Jin Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Daegu University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Depression, Healthy Aging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daegu University.
Themen: Depression
Abstract (Originalsprache)
Background
Depression is a widely prevalent, often recurrent condition. To analyze the regional differences in depressive symptoms over time, we investigated urban–rural differences in change in depression over time in South Korea and the association between healthy aging and depressive symptoms among middle-aged and older adults.
Methods
Data collected in the Korean Longitudinal Study of Aging, from 2006 to 2020, of adult participants aged ≥45 years without depressive symptoms were analyzed. Healthy aging was defined under five principal components: absence of chronic disease, good physical function, normal cognitive function, active social engagement, and good psychological adaptation. Depressive symptoms were measured using the short version of the Center for Epidemiologic Studies Depression Scale. Using the Andersen-Gill model for recurrent time-to-event, we examined the effect of healthy aging on depressive symptoms, with a subgroup analysis based on the residential area.
Results
Of the 7,708 participants, 78.2% lived in urban areas and 39.4% achieved healthy aging. In 2008, rural residents had a higher incidence of depressive symptoms (rural 11.8%; urban 8.9%); however, after 2016, the depressive symptoms of urban residents gradually increased (rural 6.4%; urban 12.1%). Unhealthy aging (adjusted hazard ratio = 3.04, 95% confidence interval: 2.72–3.39) and urban residence (adjusted hazard ratio = 1.15, 95% confidence interval: 1.06–1.24) were risk factors for depressive symptoms. The subgroup analysis revealed that individuals who did not achieve healthy aging had an increased risk of depressive symptoms, regardless of their residential area (hazard ratio [95% confidence interval]: urban, 3.13 [2.75–3.55]; rural 2.59 [2.05–3.28]).
Conclusion
As urbanization accelerates, urban residents have a higher risk of depressive symptoms than rural residents. Healthy aging is an essential factor in reducing depressive symptoms. To achieve healthy aging, appropriate interventions and policies that target the middle-aged adults and gradually extend to older adults are needed, considering individual and regional factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Daegu University, Daegu, Republic of Korea.
- Department of Statistics, Daegu University, Gyeongsan, Cheongju-si, Republic of Korea.
- Department of Nursing, Cheongju University, Cheongju-si, Republic of Korea.
Förderung
- Daegu University
Zitieren
APA
Kang, S. J., Hwang, J., Kim, D., & Kim, B. (2024). Regional differences in the effects of healthy aging on depressive symptoms: a Korean longitudinal study of aging (2006–2020). Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1256368
Vancouver
Kang SJ, Hwang J, Kim D, Kim B. Regional differences in the effects of healthy aging on depressive symptoms: a Korean longitudinal study of aging (2006–2020). Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1256368
BibTeX
@article{Kang2024,
author = {Kang, Soo Jin and Hwang, Jinseub and Kim, Dohyang and Kim, Bongjeong},
title = {Regional differences in the effects of healthy aging on depressive symptoms: a Korean longitudinal study of aging (2006–2020)},
journal = {Frontiers in Public Health},
year = {2024},
volume = {12},
doi = {10.3389/fpubh.2024.1256368}
}
EUVIMED